Shuang Qu et al. reported that PD-L1-lnc, an alternative splicing gene product of PD-L1, can promote lung adenocarcinoma (LUAD) proliferation by enhancing MYC transcriptional activity [106]. The gene discussed is CD274; the disease is lung adenocarcinoma.